The Radiofrequency Ablation Catheter Market Size is valued at 4237.92 Million in 2023 and is predicted to reach 9,166.28 Million by the year 2031 at a 10.25% CAGR during the forecast period for 2024-2031. Catheter ablation is a medical procedure that is used to treat some types of arrhythmia. Heart arrhythmia is group of condition leads to irregular heartbeat. During this procedure a long, thin, flexible tube is placed into blood...
Report ID: 1063 |
Delivery: Immediate |
Published: August 2024 |
No. of Pages: 190
Remote Catheter Manipulation Device Market is expected to grow at a 6.5% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: The increasing cases of cardiovascular conditions such as arrhythmias, coronary artery disease, and heart failure necessitate advanced catheterization procedures, boosting the demand for remote catheter manipulation devices. Minimally invasive techniques are becoming i...
Report ID: 1062 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 190
Infliximab Biosimilar Market Size is valued at XX Million in 2024 and is predicted to reach XX Million by the year 2034 at an XX % CAGR during the forecast period for 2025-2034. Infliximab is chimeric anti-TNF monoclonal antibody approved for the treatment of Chron’s Disease. It is also approved for the treatment of other autoimmune diseases such as Psoriasis, rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, and others. It is...
Report ID: 1060 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 180
The Enzyme Immunoassay (EIA) Reagents and Kits Market Size is valued at 19.80 Billion in 2022 and is predicted to reach 31.60 Billion by the year 2031 at an 5.5 % CAGR during the forecast period for 2023-2031. Enzyme Immunoassay (EIA) test is one of laboratory technology that is used for measuring the concentration of analytes such as antigen and antibodies in solution. Enzyme Immunoassay (EIA) test includes various types of enzymes such as al...
Report ID: 1059 |
Delivery: Immediate |
Published: November 2024 |
No. of Pages: 170
Global Adalimumab Biosimilar Market Size is estimated to grow at the CAGR of 23.0% during the forecast period for 2025-2034. Adalimumab is a human monoclonal antibody that inhibits tumor necrosis factor (TNF), which is a soluble inflammatory cytokine, to treat autoimmune disorders. Adalimumab binds to TNF-alpha (TNF-), blocking it from activating TNF receptors, which are responsible for autoimmune disorders' inflammatory responses. Adalimum...
Report ID: 1058 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 180
CBD (Cannabidiol) Oil Market Size is valued at 7.2 Billion in 2024 and is predicted to reach 39.7 Billion by the year 2034 at a 18.7% CAGR during the forecast period for 2025-2034. CBD (Cannabidiol) Oil Market Size, Share & Trends Analysis Report By Product (Hemp Oil, Marijuana Oil), By Application (Pharmaceuticals, Food and Beverages, Cosmetics, Others), By Distribution Channel, By Region, And Segment Forecasts, 2025-2034. CBD (Cannabidi...
Report ID: 1057 |
Delivery: Immediate |
Published: December 2025 |
No. of Pages: 180
Global Insulin Patch Pump Market Size is valued at USD 984.9 Mn in 2024 and is predicted to reach USD 2600.1 Mn by the year 2034 at a 10.4% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: Insulin patch pumps offer a needle-free alternative, which enhances patient comfort and compliance, thereby driving market growth. The rise in healthcare expenditure globally, the...
Report ID: 1056 |
Delivery: Immediate |
Published: July 2025 |
No. of Pages: 190
The Neurovascular Embolization Devices Market Size is valued at USD 1.44 Billion in 2023 and is predicted to reach USD 2.41 Billion by the year 2031 at a 6.75% CAGR during the forecast period for 2024-2031. These coils are prescription equipment implanted into the aneurysm sac by a physician to block blood flow and promote thrombosis. Since coil-treated aneurysms may have residual filling or recur, placing the patient at r...
Report ID: 1055 |
Delivery: Immediate |
Published: March 2024 |
No. of Pages: 190
Global Peripheral Vascular Devices Market Size is valued at USD 10.9 Bn in 2024 and is predicted to reach USD 19.8 Bn by the year 2034 at a 6.2% CAGR during the forecast period for 2025-2034. Peripheral vascular disease (PVD) is caused due to accumulation of plaque within the inside lining of arteries. With the increasing age, the incidence of PVD also increases. It is more common among the diabetic and smoking population. More than 5% of ...
Report ID: 1054 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 190
Medication Error Reporting Market Size is valued at USD 600.34 Million in 2024 and is predicted to reach USD 2403.28 Million by the year 2034 at a 15.0% CAGR during the forecast period for 2025-2034. According to the most recent study by InsightAce Analytic.Medication errors, broadly defined as any error in the prescribing, dispensing, or administration of a drug, irrespective of whether such errors lead to adverse consequences or not, are the...
Report ID: 1053 |
Delivery: Immediate |
Published: April 2025 |
No. of Pages: 170
Pharmaceuticals